LINC00974: A Potential Drug Target and Biomarker (G147093)

Target Name: LINC00974

NCBI ID: G147093

LINC00974

Other Name(s): Long intergenic non-protein coding RNA 974 | long intergenic non-protein coding RNA 974

LINC00974: A Potential Drug Target and Biomarker

LINC00974 is a non-coding RNA (ncRNA) molecule that has been identified as a potential drug target and biomarker. It is a long intergenic non-protein coding RNA (lncRNA), which means it is not a protein but rather a RNA molecule that has a function in gene expression. LINC00974 is a highly conserved gene that is expressed in many different organisms, including humans.

The Discovery of LINC00974

LINC00974 was first identified using bioinformatics tools that were designed to search for highly conserved RNA molecules. The LINC00974 gene was identified and its expression was validated using RNA sequencing (RNA-seq) data. RNA-seq is a technique that allows researchers to identify the expressed RNA molecules in a cell or organism. By analyzing the RNA-seq data, researchers can identify the gene expression patterns of an organism and gain insights into the functions of the genes.

The Potential Drug Target

LINC00974 is a potential drug target because it is highly conserved and has been shown to play a role in several cellular processes. LINC00974 is involved in cell adhesion, which is a critical process for the development and maintenance of tissues and organs. It is also involved in the regulation of cell growth, which is important for the growth and development of tissues and organs. In addition, LINC00974 is involved in the regulation of cell survival, which is important for the maintenance of tissues and organs.

The Potential Biomarker

LINC00974 may also be a potential biomarker for several diseases. For example, LINC00974 is involved in the regulation of cell adhesion, which is a critical process for the development and maintenance of tissues and organs. Therefore, LINC00974 may be a potential biomarker for diseases that are characterized by the disruption of cell adhesion, such as cancer. In addition, LINC00974 is involved in the regulation of cell growth, which is important for the growth and development of tissues and organs. Therefore, LINC00974 may be a potential biomarker for diseases that are characterized by the disruption of cell growth, such as neurodegenerative diseases.

The Future of LINC00974

The discovery of LINC00974 as a potential drug target and biomarker opens up new avenues of research. Researchers are now working to understand the mechanisms of LINC00974 and how it functions as a drug target and biomarker. This research will be important for the development of new treatments for diseases that are characterized by the disruption of cell adhesion or cell growth.

Conclusion

LINC00974 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its conservation and involvement in several cellular processes make it an attractive candidate for further research. Further studies are needed to understand the mechanisms of LINC00974 and its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 974

The "LINC00974 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00974 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets